Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 37,088 | 48,336 | 40,477 | 40,159 | 35,064 |
| Cost of Goods | 16,050 | 18,962 | 13,615 | 15,598 | 14,887 |
| Gross Profit | 21,038 | 29,374 | 26,862 | 24,561 | 20,177 |
| Operating Expenses | 33,250 | 30,252 | 26,117 | 26,050 | 23,421 |
| Operating Income | -12,162 | 84 | 1,360 | -891 | -2,357 |
| Interest Expense | 673 | 687 | 649 | 647 | 590 |
| Other Income | 3,795 | 4,717 | 1,139 | 137 | -356 |
| Pre-tax Income | -9,040 | 4,114 | 1,850 | -1,401 | -3,303 |
| Income Tax | -2,233 | 396 | 224 | -699 | -1,145 |
| Net Income Continuous | -6,807 | 3,718 | 1,626 | -702 | -2,158 |
| Minority Interests | N/A | 189 | -40 | -104 | -137 |
| Net Income | $-6,807 | $3,529 | $1,666 | $-598 | $-2,021 |
| EPS Basic Total Ops | -0.05 | 0.03 | 0.01 | 0.00 | -0.02 |
| EPS Basic Continuous Ops | -0.05 | 0.03 | 0.01 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.05 | 0.03 | 0.01 | 0.00 | -0.02 |
| EPS Diluted Continuous Ops | -0.05 | 0.03 | 0.01 | -0.01 | -0.02 |
| EBITDA(a) | $-10,361 | $1,948 | $2,131 | $663 | $-887 |